JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on April 21, 2004; DOI: 10.1124/jpet.104.067751


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.104.067751v1
310/3/1152    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oz, M.
Right arrow Articles by Lupica, C. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oz, M.
Right arrow Articles by Lupica, C. L.


Received for publication March 1, 2004.
Revised April 12, 2004.
Accepted for publication April 13, 2004.

DIFFERENTIAL EFFECTS OF ENDOGENOUS AND SYNTHETIC CANNABINOIDS ON {alpha}7-NICOTINIC ACETYLCHOLINE RECEPTOR-MEDIATED RESPONSES IN XENOPUS OOCYTES

Murat Oz 1*, Li Zhang 2, Arippa Ravindran 2, Marisela Morales 3, Carl L. Lupica 1

1 National Institute on Drug Abuse, NIH/DHHS, Intramural Research Program, Cellular Neurobiology Br. 2 National Institute on Alcohol Abuse & Alcoholism, NIH/DHHS, L MCN 3 National Institute on Drug Abuse, NIH/DHHS, Intramural Research Program, Behavioral Neurobiology Br.

* Address correspondence to: E-mail: moz{at}intra.nida.nih.gov

Abstract

The effects of endogenous and synthetic cannabinoid receptor agonists including 2-arachidonoylglycerol, R-methanandamide, WIN55,212-2, CP55,940 and the psychoactive constituent of marijuana, {Delta}9-THC, on the function of homomeric {alpha}7 nicotinic ACh receptors expressed in Xenopus oocytes was investigated using the two-electrode voltage-clamp technique. The endogenous cannabinoid receptor ligands 2-arachidonoylglycerol and the metabolically stable analogue of anandamide, R-methanandamide, reversibly inhibited currents evoked with ACh (100 µM) in a concentration-dependent manner (IC50 values of 168 nM and 183 nM, respectively). In contrast, the synthetic cannabinoid receptor agonists CP55,940, WIN55,212-2, and the phytochemical {Delta}9-THC did not alter {alpha}7 nicotinic ACh receptor function. The inhibition of {alpha}7-mediated currents by 2-arachidonylglycerol was found to be non-competitive and voltage-independent. Additional experiments using endocannabinoid metabolites suggested that arachidonic acid, but not ethanolamine or glycerol, could also inhibit the {alpha}7-nACh receptor function. Whereas the effects of arachidonic acid were also noncompetitive and voltage-independent, its potency was much lower than 2-AG and anandamide. Results of studies with chimeric {alpha}7-nACh-5-HT3 receptors that were comprised of the amino-terminal domain of the {alpha}7-nACh receptor and the transmembrane and carboxyl-terminal domains of 5-HT3 receptors indicated that the site of interaction of the endocannabinoids with the {alpha}7-nAChR was not located on the N-terminal region of the receptor. These data indicate that cannabinoid receptor ligands that are produced in-situ potently inhibit {alpha}7-nACh receptor function, whereas the synthetic cannabinoid ligands, and {Delta}9-THC, are without effect or are relatively ineffective at inhibiting these receptors.


Key words: arachidonic acid, cannabinoids, drug abuse, endocannabinoids, nicotinic receptors, xenopus oocytes


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
U. Baranowska, M. Gothert, R. Rudz, and B. Malinowska
Methanandamide Allosterically Inhibits in Vivo the Function of Peripheral Nicotinic Acetylcholine Receptors Containing the {alpha}7-Subunit
J. Pharmacol. Exp. Ther., September 1, 2008; 326(3): 912 - 919.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. E. Spivak, C. R. Lupica, and M. Oz
The Endocannabinoid Anandamide Inhibits the Function of {alpha}4beta2 Nicotinic Acetylcholine Receptors
Mol. Pharmacol., October 1, 2007; 72(4): 1024 - 1032.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
H. Schuel and L. J. Burkman
A Tale of Two Cells: Endocannabinoid-Signaling Regulates Functions of Neurons and Sperm
Biol Reprod, December 1, 2005; 73(6): 1078 - 1086.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Oz, S. N. Jackson, A. S. Woods, M. Morales, and L. Zhang
Additive Effects of Endogenous Cannabinoid Anandamide and Ethanol on {alpha}7-Nicotinic Acetylcholine Receptor-Mediated Responses in Xenopus Oocytes
J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1272 - 1280.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.